Fundacion IDEAA
Quick facts
Marketed products
- Emtricitabine / Tenofovir Disoproxil Pill · Infectious Disease / Virology
Emtricitabine and tenofovir disoproxil are nucleoside/nucleotide reverse transcriptase inhibitors that block HIV replication by inhibiting the enzyme responsible for converting viral RNA into DNA.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Fundacion IDEAA
What are Fundacion IDEAA's marketed drugs?
Top marketed products include Emtricitabine / Tenofovir Disoproxil Pill.
Related
- Emtricitabine / Tenofovir Disoproxil Pill · Infectious Disease / Virology
- Sector hub: All tracked pharma companies